Chemical Formula: C15H18N2

Chemical Formula C15H18N2

Found 34 metabolite its formula value is C15H18N2

4,4-Methylene di-o-toluidine

4,4`-Methylen-bis(2-methyl aniline)

C15H18N2 (226.1469908)


CONFIDENCE standard compound; INTERNAL_ID 322; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5346; ORIGINAL_PRECURSOR_SCAN_NO 5344 CONFIDENCE standard compound; INTERNAL_ID 322; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5297; ORIGINAL_PRECURSOR_SCAN_NO 5295 CONFIDENCE standard compound; INTERNAL_ID 322; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5346; ORIGINAL_PRECURSOR_SCAN_NO 5345 CONFIDENCE standard compound; INTERNAL_ID 322; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5344; ORIGINAL_PRECURSOR_SCAN_NO 5342 CONFIDENCE standard compound; INTERNAL_ID 322; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5314; ORIGINAL_PRECURSOR_SCAN_NO 5313 CONFIDENCE standard compound; INTERNAL_ID 322; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5349; ORIGINAL_PRECURSOR_SCAN_NO 5348 CONFIDENCE standard compound; INTERNAL_ID 4142

   

6-Methylergoline

7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline

C15H18N2 (226.1469908)


An ergoline alkaloid obtained by selective methylation of the N-6 position of ergoline.

   

Pirlindole

12-methyl-1,4-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-9(16),10,12,14-tetraene

C15H18N2 (226.1469908)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor D000970 - Antineoplastic Agents

   

Indoloquinolizidine

Indoloquinolizidine

C15H18N2 (226.1469908)


   

N-Desmethylpheniramine

N-Desmethylpheniramine

C15H18N2 (226.1469908)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3420 CONFIDENCE standard compound; INTERNAL_ID 2122

   

N-Isopropyl-N-phenyl-p-phenylenediamine

N-Isopropyl-N-phenyl-1,4-phenylenediamine

C15H18N2 (226.1469908)


D020011 - Protective Agents > D000975 - Antioxidants CONFIDENCE standard compound; INTERNAL_ID 2425

   
   

N-isopropyl-N-phenyl-p-phenylenediamine

N-Isopropyl-N-phenyl-1,4-phenylenediamine

C15H18N2 (226.1469908)


D020011 - Protective Agents > D000975 - Antioxidants CONFIDENCE standard compound; INTERNAL_ID 4137

   

NPE_227.1543_9.6

NPE_227.1543_9.6

C15H18N2 (226.1469908)


CONFIDENCE Parent Substance with Reference Standard (Level 1); INTERNAL_ID 1100

   

Monodesmethylpheniramine

Monodesmethylpheniramine

C15H18N2 (226.1469908)


   

4,4-METHYLENEBIS(N-METHYLANILINE)

4,4-METHYLENEBIS(N-METHYLANILINE)

C15H18N2 (226.1469908)


   

4-[(4-aminophenyl)methyl]-2-ethylaniline

4-[(4-aminophenyl)methyl]-2-ethylaniline

C15H18N2 (226.1469908)


   

Cyclohexanamine,N-(1H-indol-3-ylmethylene)-

Cyclohexanamine,N-(1H-indol-3-ylmethylene)-

C15H18N2 (226.1469908)


   

1-cyclohexyl-5-phenylimidazole

1-cyclohexyl-5-phenylimidazole

C15H18N2 (226.1469908)


   

6-(azepan-2-yl)quinoline

6-(azepan-2-yl)quinoline

C15H18N2 (226.1469908)


   

(4-ETHOXY-BENZOYLAMINO)-ACETICACID

(4-ETHOXY-BENZOYLAMINO)-ACETICACID

C15H18N2 (226.1469908)


   

3-Azepan-2-yl-quinoline

3-Azepan-2-yl-quinoline

C15H18N2 (226.1469908)


   

2-(4-Ethylphenyl)-5-propylpyrimidine

2-(4-Ethylphenyl)-5-propylpyrimidine

C15H18N2 (226.1469908)


   

1-(1,3-BENZODIOXOL-5-YL)-4,4,4-TRIFLUOROBUTANE-1,3-DIONE

1-(1,3-BENZODIOXOL-5-YL)-4,4,4-TRIFLUOROBUTANE-1,3-DIONE

C15H18N2 (226.1469908)


   

cyclopentyl(quinolin-2-yl)methanamine

cyclopentyl(quinolin-2-yl)methanamine

C15H18N2 (226.1469908)


   

Benzenamine,4,4-methylenebis[3-methyl-

Benzenamine,4,4-methylenebis[3-methyl-

C15H18N2 (226.1469908)


   

5-AZEPAN-2-YL-QUINOLINE

5-AZEPAN-2-YL-QUINOLINE

C15H18N2 (226.1469908)


   

Pentamethyl-1,3-benzenediacetonitrile

Pentamethyl-1,3-benzenediacetonitrile

C15H18N2 (226.1469908)


   

8-AZEPAN-2-YL-QUINOLINE

8-AZEPAN-2-YL-QUINOLINE

C15H18N2 (226.1469908)


   

1-(1-Naphthylmethyl)piperazine

1-(1-Naphthylmethyl)piperazine

C15H18N2 (226.1469908)


   

N-benzyl-N-phenylethane-1,2-diamine

N-benzyl-N-phenylethane-1,2-diamine

C15H18N2 (226.1469908)


   

2,2-bis-(4-Aminophenyl)propane

2,2-bis-(4-Aminophenyl)propane

C15H18N2 (226.1469908)


   

3-Methyl-8-(piperidin-3-yl)quinoline

3-Methyl-8-(piperidin-3-yl)quinoline

C15H18N2 (226.1469908)


   

2-(Piperidin-1-yl)-2,3-dihydro-1H-indene-2-carbonitrile

2-(Piperidin-1-yl)-2,3-dihydro-1H-indene-2-carbonitrile

C15H18N2 (226.1469908)


   

(4-Ethyl-benzyl)-pyridin-3-ylmethyl-amine

(4-Ethyl-benzyl)-pyridin-3-ylmethyl-amine

C15H18N2 (226.1469908)


   

Pirlindole

Pirlindole

C15H18N2 (226.1469908)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor D000970 - Antineoplastic Agents

   

1,2,3,4,8,9,10,11-octahydro-[1,4]diazepino[6,7,1-jk]carbazole

1,2,3,4,8,9,10,11-octahydro-[1,4]diazepino[6,7,1-jk]carbazole

C15H18N2 (226.1469908)


   
   

(12br)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(12br)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C15H18N2 (226.1469908)